12:00 AM
Sep 27, 2010
 |  BC Week In Review  |  Company News  |  Deals

Asthmatx, Boston Scientific deal

Boston Scientific will acquire fellow medical device company Asthmatx for $193.5 million up front in cash, plus up to $250 million in revenue-based milestones. Asthmatx markets its Alair bronchial thermoplasty system,...

Read the full 131 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >